PEG-site infections Infectie van de PEG-insteekopening
Conditions
Interventions
Group 1: Standard treatment with local antibiotic ointment (Fucidin ointment)
Group 2: Treatment with silver-impregnated dressing (Atrauman AG).
Sponsors
VU Medical Center, Amsterdam
Eligibility
Inclusion criteria
Inclusion criteria: 1. Signed informed consent; 2. PEG-site infection graded as type 1 & 2 (1= early signs of inflammation,proactive measures, 2= Requiring local antiseptic/antibiotic care); 3. Male and female participants age 18 and older; 4. PEG insertion procedure longer than 1 week prior to randomization; 5. Patient or guardian is able to fully comprehend and perform study procedures.
Exclusion criteria
Exclusion criteria: 1. Estimated life expectancy less than one month; 2. Concurrent use of oral antibiotics for other diagnosis; 3. Signs and symptoms of concurrent disease for which the subject is expected to start antibiotic treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the reduction or increase in peristomal sepsis scoring in both groups using the scoring scale of Jain et al. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The number of patients in which the PEG - site infection was regarded as healed; 2. Percentage decrease in number of bacterial species as measured by the IS-pro; 3. Treatment related adverse events; 4. Recurrence of infection 1 week after healing; 5. Deterioration of the infection-site that will require withdrawal. | — |
Contacts
Public ContactEsmé Clasquin
De Boelelaan 1118
Outcome results
None listed